findmyKOL
Clinical trialNCT01468246Active, not recruitingObservational

The Young Women's Breast Cancer Study

SponsorDana-Farber Cancer InstituteEnrollment1,302Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigators are conducting a longitudinal cohort study of young women with breast cancer. The investigators identify women age 40 and younger with newly-diagnosed breast cancer from academic and community healthcare institutions. After women consent to the study, they fill-out surveys and give blood samples, and the investigators collect tissue from their breast cancer tumor after it is removed. Women are surveyed every 6 months for the first 3 years after diagnosis, then yearly thereafter for an additional 7 years (for a total follow-up of at least 10 years following diagnosis). The study investigates short and long-term disease and treatment issues, tumor biology and the relationship to patient outcomes, and psychosocial concerns at baseline and in follow-up among a cohort of young women who are newly-diagnosed with breast cancer.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, Canada

United States
  • University of Colorado Cancer Center

    Aurora, Colorado, United States

  • Beth-Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Mgh/north Shore Cancer Center

    Danvers, Massachusetts, United States

  • Cape Cod Hospital

    Hyannis, Massachusetts, United States

  • Lowell General Hospital

    Lowell, Massachusetts, United States

  • Df/bwcc at Milford Regional Medical Center

    Milford, Massachusetts, United States

  • Newton-Wellesley Hospital

    Newton, Massachusetts, United States

  • South Shore Hospital

    South Weymouth, Massachusetts, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Dana-Farber/new Hampshire Oncology-Hematology

    Londonderry, New Hampshire, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2006
Primary completion
31 Jan 2035
Completion
31 Jan 2035
Last update posted
3 Feb 2026
Registered enrollment
1,302
Registry id
NCT01468246

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.